186 related articles for article (PubMed ID: 20075714)
41. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) in previously treated ovarian cancer patients.
Lund B; Hansen OP; Theilade K; Hansen M; Neijt JP
J Natl Cancer Inst; 1994 Oct; 86(20):1530-3. PubMed ID: 7932808
[TBL] [Abstract][Full Text] [Related]
42. 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study.
Michael A; Hill M; Maraveyas A; Dalgleish A; Lofts F
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):150-3. PubMed ID: 17355112
[TBL] [Abstract][Full Text] [Related]
43. Clinical impact of radiotherapy for locally advanced pancreatic cancer.
Sawaki A; Hoki N; Ito S; Matsumoto K; Mizuno N; Hara K; Takagi T; Kobayashi Y; Sawai Y; Kawai H; Tajika M; Nakamura T; Yamao K
J Gastroenterol; 2009; 44(12):1209-14. PubMed ID: 19705054
[TBL] [Abstract][Full Text] [Related]
44. Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer.
Goldstein D; Van Hazel G; Walpole E; Underhill C; Kotasek D; Michael M; Shapiro J; Davies T; Reece W; Harvey J; Spry N
Br J Cancer; 2007 Aug; 97(4):464-71. PubMed ID: 17653074
[TBL] [Abstract][Full Text] [Related]
45. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas.
Kachnic LA; Shaw JE; Manning MA; Lauve AD; Neifeld JP
Int J Cancer; 2001 Apr; 96(2):132-9. PubMed ID: 11291097
[TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma.
Takeda Y; Nakamori S; Eguchi H; Kobayashi S; Marubashi S; Tanemura M; Konishi K; Yoshioka Y; Umeshita K; Mori M; Doki Y; Nagano H
Jpn J Clin Oncol; 2014 Dec; 44(12):1172-80. PubMed ID: 25425728
[TBL] [Abstract][Full Text] [Related]
47. Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma.
Pattaranutaporn P; Thirapakawong C; Chansilpa Y; Therasakvichya S; Ieumwananontachai N; Thephamongkhol K
Gynecol Oncol; 2001 Jun; 81(3):404-7. PubMed ID: 11371129
[TBL] [Abstract][Full Text] [Related]
48. Irinotecan plus gemcitabine induces both radiographic and CA 19-9 tumor marker responses in patients with previously untreated advanced pancreatic cancer.
Rocha Lima CM; Savarese D; Bruckner H; Dudek A; Eckardt J; Hainsworth J; Yunus F; Lester E; Miller W; Saville W; Elfring GL; Locker PK; Compton LD; Miller LL; Green MR
J Clin Oncol; 2002 Mar; 20(5):1182-91. PubMed ID: 11870159
[TBL] [Abstract][Full Text] [Related]
49. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
Duffy A; Kortmansky J; Schwartz GK; Capanu M; Puleio S; Minsky B; Saltz L; Kelsen DP; O'Reilly EM
Ann Oncol; 2008 Jan; 19(1):86-91. PubMed ID: 17878176
[TBL] [Abstract][Full Text] [Related]
50. Stereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pilot trial demonstrating safety.
Gurka MK; Collins SP; Slack R; Tse G; Charabaty A; Ley L; Berzcel L; Lei S; Suy S; Haddad N; Jha R; Johnson CD; Jackson P; Marshall JL; Pishvaian MJ
Radiat Oncol; 2013 Mar; 8():44. PubMed ID: 23452509
[TBL] [Abstract][Full Text] [Related]
51. Efficacy and factors affecting outcome of gemcitabine concurrent chemoradiotherapy in patients with locally advanced pancreatic cancer.
Huang PI; Chao Y; Li CP; Lee RC; Chi KH; Shiau CY; Wang LW; Yen SH
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):159-65. PubMed ID: 18508203
[TBL] [Abstract][Full Text] [Related]
52. [Locally advanced unresectable pancreatic cancer: Induction chemoradiotherapy followed by maintenance gemcitabine versus gemcitabine alone: Definitive results of the 2000-2001 FFCD/SFRO phase III trial].
Barhoumi M; Mornex F; Bonnetain F; Rougier P; Mariette C; Bouché O; Bosset JF; Aparicio T; Mineur L; Azzedine A; Hammel P; Butel J; Stremsdoerfer N; Maingon P; Bedenne L; Chauffert B
Cancer Radiother; 2011 Jun; 15(3):182-91. PubMed ID: 21315644
[TBL] [Abstract][Full Text] [Related]
53. A phase II study of alternating cycles of split course radiation therapy and gemcitabine chemotherapy for inoperable pancreatic or biliary tract carcinoma.
Lin LL; Picus J; Drebin JA; Linehan DC; Solis J; Strasberg SM; Tan B; Thorstad WL; Myerson R
Am J Clin Oncol; 2005 Jun; 28(3):234-41. PubMed ID: 15923794
[TBL] [Abstract][Full Text] [Related]
54. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.
Abou-Alfa GK; Letourneau R; Harker G; Modiano M; Hurwitz H; Tchekmedyian NS; Feit K; Ackerman J; De Jager RL; Eckhardt SG; O'Reilly EM
J Clin Oncol; 2006 Sep; 24(27):4441-7. PubMed ID: 16983112
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study.
Van Laethem JL; Hammel P; Mornex F; Azria D; Van Tienhoven G; Vergauwe P; Peeters M; Polus M; Praet M; Mauer M; Collette L; Budach V; Lutz M; Van Cutsem E; Haustermans K
J Clin Oncol; 2010 Oct; 28(29):4450-6. PubMed ID: 20837948
[TBL] [Abstract][Full Text] [Related]
56. Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer.
Epelbaum R; Rosenblatt E; Nasrallah S; Faraggi D; Gaitini D; Mizrahi S; Kuten A
J Surg Oncol; 2002 Nov; 81(3):138-43. PubMed ID: 12407726
[TBL] [Abstract][Full Text] [Related]
57. Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience.
Ohguri T; Imada H; Yahara K; Narisada H; Morioka T; Nakano K; Korogi Y
Radiat Med; 2008 Dec; 26(10):587-96. PubMed ID: 19132489
[TBL] [Abstract][Full Text] [Related]
58. A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer.
Dimcevski G; Kotopoulis S; Bjånes T; Hoem D; Schjøtt J; Gjertsen BT; Biermann M; Molven A; Sorbye H; McCormack E; Postema M; Gilja OH
J Control Release; 2016 Dec; 243():172-181. PubMed ID: 27744037
[TBL] [Abstract][Full Text] [Related]
59. Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: gemcitabine versus 5-fluorouracil, a randomized controlled study.
Li CP; Chao Y; Chi KH; Chan WK; Teng HC; Lee RC; Chang FY; Lee SD; Yen SH
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):98-104. PubMed ID: 12909221
[TBL] [Abstract][Full Text] [Related]
60. Concurrent infusional gemcitabine and radiation in the treatment of advanced unresectable GI malignancy: a phase I study.
Mohiuddin M; Kudrimoti M; Regine WF; McGrath PC; Hanna N; John W
Cancer J; 2002; 8(3):255-62. PubMed ID: 12074325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
